The School of Medicine, Medical Sciences and Nutrition University of Aberdeen Aberdeen UK.
Department of Neurology National Neuroscience Institute Singapore City Singapore.
Brain Behav. 2018 Apr 10;8(5):e00960. doi: 10.1002/brb3.960. eCollection 2018 May.
The Brighton Collaboration criteria have standardized the clinical and laboratory-supported diagnosis of Guillain-Barré syndrome (GBS) and Miller Fisher syndrome (MFS) in a way that is applicable in many parts of the world with variable resources. The caveat within the criteria, "absence of an identified alternative diagnosis for weakness" makes GBS a diagnosis of exclusion. Accurate diagnosis of GBS requires a good understanding of an updated, locally contextualised list of mimics, and features that distinguish them from GBS.
布莱顿协作组织制定的诊断标准使吉兰-巴雷综合征(GBS)和米勒-费雪综合征(MFS)的临床和实验室支持诊断变得标准化,这些标准在资源情况各不相同的世界各地都具有适用性。标准中的警告语“无其他可识别的弱点病因诊断”使 GBS 成为一种排除性诊断。准确诊断 GBS 需要充分了解最新的、具有当地背景的类似疾病列表,以及将它们与 GBS 区分开来的特征。